金城医药

300233 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

5.4B ($785.6M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

3.4B

Net Income

208.0M

Gross Margin

N/A

Op. Margin

7.9%

Net Margin

6.2%

ROE

5.4%

ROA

3.7%

D/E

0.46

Dividend Yield

N/A

EPS

0.52

Current Ratio

1.83

Price History

Company Info

Industry	C27医药制造业
Market Segment	ChiNext
Currency	CNY
Fiscal Year	2024

Business Overview

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 金城医药

Ticker	300233
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业